Journal
PSYCHIATRY RESEARCH
Volume 261, Issue -, Pages 148-153Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.psychres.2017.12.025
Keywords
Schizophrenia; C Reactive Protein; SNP; Genetic association; Polygenic risk score
Categories
Funding
- Stanley Medical Research Institute [07R-1712, 07R-1690]
- National Institute of Health [MH63480, MH93246, D43 TW009114]
Ask authors/readers for more resources
Several studies have indicated infectious and immune-related abnormalities in schizophrenia (Scz), including elevated serum C-reactive protein (CRP)-a well-known proxy for infections/immune abnormalities. A portion of the genetic risk for Scz can be estimated using the polygenic risk score (PGRS). It is not known whether there is an interaction in the risks traceable to CRP and PGRS. Patients with Scz and individuals without psychosis were evaluated systematically using DSM IV criteria (N=794, N = 446, respectively). To estimate risk for Scz attributable to CRP and PGRS, serum from these participants was assayed for CRP levels using enzyme linked immunosorbent assays. PGRS was estimated from common DNA polymorphisms associated with Scz from genome wide association studies. CRP level and PGRS were not significantly correlated. Using a generalized linear logistic model, case/control status was evaluated in relation to the following predictors: CRP, PGRS, and demographic variables. CRP and PGRS were individually associated with case status; CRP: odds ratio (OR) 1.27, 95% confidence intervals (95% Cl) 1.12, 1.43; p = 0.0001; PGRS: OR 1.66, 95% CI 1.47, 1.89; p = 1.28 x 10-15. There were no significant interactions between PGRS and CRP for predicting Scz versus control status.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available